These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3802300)

  • 1. Pharmacokinetic studies on ceftezole.
    Fraschini F; Scaglione F; De Pascale A; Del Mastro S
    Chemioterapia; 1986 Dec; 5(6):388-90. PubMed ID: 3802300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of ceftezole in patients with normal and impaired renal function.
    Ohkawa M; Kuroda K
    Chemotherapy; 1980; 26(4):242-7. PubMed ID: 7389424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacology phase I of cefazedone, a new cephalosporin, in healthy volunteers. II. Pharmacokinetics in comparison with cefazolin.
    Pabst J; Leopold G; Ungethüm W; Dingeldein E
    Arzneimittelforschung; 1979; 29(2a):437-43. PubMed ID: 582722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftezole, a new cephalosporin C derivative II. Distribution and excretion in parenteral administration.
    Harada Y; Matsubara S; Kakimoto M; Noto T; Nehashi T
    J Antibiot (Tokyo); 1976 Oct; 29(10):1071-82. PubMed ID: 994326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic studies of cefuroxime in patients with liver cirrhosis.
    Okolicsanyi L; Venuti M; Orlando R; Xerri L; Pugina M
    Arzneimittelforschung; 1982; 32(7):777-82. PubMed ID: 6889880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic study of cefazaflur compared to cephalothin and cefazolin.
    Harvengt C; Muenier H; Lamy F
    J Clin Pharmacol; 1977; 17(2-3):128-33. PubMed ID: 833342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo evaluation of ceftezole, a new cephalosporin derivative.
    Nishida M; Murakawa T; Kamimura T; Okada N; Sakamoto H; Fukada S; Nakamoto S; Yokota Y; Miki K
    Antimicrob Agents Chemother; 1976 Jul; 10(1):1-13. PubMed ID: 825020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacology phase I of cefazedone, a new cephalosporin, in healthy volunteers. I. Tolerance in comparison with cefazolin.
    Ungethüm W; Leopoid G
    Arzneimittelforschung; 1979; 29(2a):435-6. PubMed ID: 582721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of moxalactam and cefazolin compared in normal volunteers.
    Srinivasan S; Fu KP; Neu HC
    Antimicrob Agents Chemother; 1981 Feb; 19(2):302-5. PubMed ID: 6214989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single intravenous and multiple intramuscular dose pharmacokinetics and tissue residue profile of gentamicin in sheep.
    Brown SA; Riviere JE; Coppoc GL; Hinsman EJ; Carlton WW; Steckel RR
    Am J Vet Res; 1985 Jan; 46(1):69-74. PubMed ID: 3970446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical study on ceftezole in oral surgery. Clinical effect of ceftezole used jointly with gamma-globulin (Gamma-Venin) (author's transl)].
    Ishikawa M; Yamamoto Y; Shimizu K; Koh T; Toyoda Y; Shimada J; Sakamoto E; Sumida H; Sakamoto M
    Jpn J Antibiot; 1981 Mar; 34(3):404-11. PubMed ID: 6169851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical experience with ceftezole (author's transl)].
    Ishikawa K
    Jpn J Antibiot; 1978 Nov; 31(11):633-5. PubMed ID: 731859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of azlocillin after intramuscular application.
    Holá V; Polívková L; Novák L
    Czech Med; 1986; 9(3):166-9. PubMed ID: 3095077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fosmidomycin: a new phosphonic acid antibiotic. Part I: Phase I tolerance studies.
    Kuemmerle HP; Murakawa T; Soneoka K; Konishi T
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):515-20. PubMed ID: 4066075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefatrizine (SK&F 60771), a new oral cephalosporin: serum levels and urinary recovery in humans after oral or intramuscular administration--comparative study with cephalexin and cefazolin.
    Actor P; Pitkin DH; Lucyszyn G; Weisbach JA; Bran JL
    Antimicrob Agents Chemother; 1976 May; 9(5):800-3. PubMed ID: 949177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetics of ceftizoxime with and without probenecid].
    Adam D; Timmler R
    Arzneimittelforschung; 1982; 32(4):416-9. PubMed ID: 6285937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Kinetics of cefotaxime in healthy subjects (author's transl)].
    Acar JF; Guibert J; Kitzis MD
    Nouv Presse Med; 1981 Feb; 10(8):559-63. PubMed ID: 6259593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on ceftezole (Celoslin) in human sputum (author's transl)].
    Kikuchi H; Seno T; Tamura S; Yamamoto T; Nabeshima K; Sugimoto T; Otsuru N; Horai Z; Sumi K; Matsuoka A
    Jpn J Antibiot; 1980 May; 33(5):554-7. PubMed ID: 7431656
    [No Abstract]   [Full Text] [Related]  

  • 19. Fosmidomycin, a new phosphonic acid antibiotic. Part II: 1. Human pharmacokinetics. 2. Preliminary early phase IIa clinical studies.
    Kuemmerle HP; Murakawa T; Sakamoto H; Sato N; Konishi T; De Santis F
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):521-8. PubMed ID: 4066076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of ceftezole (Celoslin) for respiratory infections (author's transl)].
    Sawaki M; Narita N; Takezawa Y; Adachi K; Mikami R; Matsuoka Y; Harikane O; Masutani T; Ishii Y; Ohori M; Sakuragi R
    Jpn J Antibiot; 1981 Feb; 34(2):188-93. PubMed ID: 7253199
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.